Search research articles
Contact Us
Filters
Showing results (221-230 of 234) with videos related to
Page
of 24
Sort By:
Haematologica
|
March 5, 2026
Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasone
Ricardo D Parrondo, Ricardo De Menezes, Hanna Sledge, et al.
Blood Advances
|
February 24, 2026
Early Mortality with Bispecific Antibody Therapy in RRMM: An IMWG Immunotherapy Database Real-World Analysis
Carlyn Rose Tan, Saad Z Usmani, Andriy Derkach, et al.
Circulation
|
November 10, 2025
High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis
Niklas Dyrby Johansen, Daniel Modin, Jacobo Pardo-Seco, et al.
Lancet (London, England)
|
October 20, 2025
Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis
Niklas Dyrby Johansen, Daniel Modin, Jacobo Pardo-Seco, et al.
Blood Cancer Journal
|
April 4, 2025
Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes
Abiola Bolarinwa, Madhu Nagaraj, Saurabh Zanwar, et al.
Blood
|
July 26, 2023
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas
Udit Yadav, Shaji K Kumar, Linda B Baughn, et al.
Journal of the American College of Cardiology
|
February 18, 2026
High-Dose Influenza Vaccination in Atherosclerotic Cardiovascular Disease: A Multinational Pooled Analysis of DANFLU-2 and GALFLU (FLUNITY-HD)
Manan Pareek, Niklas Dyrby Johansen, Daniel Modin, et al.
Blood
|
October 4, 2024
Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma
Surbhi Sidana, Krina K Patel, Lauren C Peres, et al.
Blood
|
August 1, 2025
Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy
Binod Dhakal, Othman Salim Akhtar, David Fandrei, et al.
Blood Advances
|
April 22, 2026
A multi-center study of progression-risk and outcomes in solitary bone plasmacytoma with and without marrow involvement
Kenneth Jc Lim, Maximilian Johannes Steinhardt, Matthew J Rees, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 234) with videos related to
Sort By:
Page
of 24
Haematologica
|
March 5, 2026
Real-world outcomes of newly diagnosed multiple myeloma patients treated with front-line daratumumab bortezomib lenalidomide and dexamethasone
Ricardo D Parrondo, Ricardo De Menezes, Hanna Sledge, et al.
Blood Advances
|
February 24, 2026
Early Mortality with Bispecific Antibody Therapy in RRMM: An IMWG Immunotherapy Database Real-World Analysis
Carlyn Rose Tan, Saad Z Usmani, Andriy Derkach, et al.
Circulation
|
November 10, 2025
High-Dose vs. Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults: The FLUNITY-HD Prespecified Pooled Analysis
Niklas Dyrby Johansen, Daniel Modin, Jacobo Pardo-Seco, et al.
Lancet (London, England)
|
October 20, 2025
Effectiveness of high-dose influenza vaccine against hospitalisations in older adults (FLUNITY-HD): an individual-level pooled analysis
Niklas Dyrby Johansen, Daniel Modin, Jacobo Pardo-Seco, et al.
Blood Cancer Journal
|
April 4, 2025
Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes
Abiola Bolarinwa, Madhu Nagaraj, Saurabh Zanwar, et al.
Blood
|
July 26, 2023
Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas
Udit Yadav, Shaji K Kumar, Linda B Baughn, et al.
Journal of the American College of Cardiology
|
February 18, 2026
High-Dose Influenza Vaccination in Atherosclerotic Cardiovascular Disease: A Multinational Pooled Analysis of DANFLU-2 and GALFLU (FLUNITY-HD)
Manan Pareek, Niklas Dyrby Johansen, Daniel Modin, et al.
Blood
|
October 4, 2024
Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma
Surbhi Sidana, Krina K Patel, Lauren C Peres, et al.
Blood
|
August 1, 2025
Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy
Binod Dhakal, Othman Salim Akhtar, David Fandrei, et al.
Blood Advances
|
April 22, 2026
A multi-center study of progression-risk and outcomes in solitary bone plasmacytoma with and without marrow involvement
Kenneth Jc Lim, Maximilian Johannes Steinhardt, Matthew J Rees, et al.
Page
of 24